Barclays downgraded Gerresheimer (GRRMF) to Underweight from Equal Weight with a price target of EUR 19, down from EUR 23. The firm prefers device manufacturing to drug containment solutions in the European medica technologies and services space.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRRMF: